Tech Center 1600 • Art Units: 1621 1622 1626 1627
This examiner grants 58% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18294191 | MICROBIOCIDAL PYRAZOLE DERIVATIVES | Non-Final OA | SYNGENTA CROP PROTECTION AG |
| 18029982 | MIXTURES CONTAINING CYCLOBUTRIFLURAM | Final Rejection | BASF SE |
| 17995806 | PI3 KINASE INHIBITORS AND USES THEREOF | Final Rejection | Purdue Research Foundation |
| 18596363 | TARGETED TREATMENT FOR SKIN FRAGILITY DISEASES | Non-Final OA | University of Washington |
| 17623060 | COMPOSITIONS AND METHODS OF TREATING LIVER CANCERS | Final Rejection | The Johns Hopkins University |
| 17996550 | 2-(HET)ARYL-SUBSTITUTED CONDENSED HETEROCYCLIC DERIVATIVES AS PEST CONTROL AGENTS | Non-Final OA | Bayer Aktiengesellschaft |
| 17767018 | NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES | Final Rejection | Bayer Aktiengesellschaft |
| 18262053 | ARTEMISININ-PROTEASOME INHIBITOR CONJUGATES AND THEIR USE IN THE TREATMENT OF DISEASE | Final Rejection | CORNELL UNIVERSITY |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy